Cite
Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature.
MLA
Smart, Alicia C., et al. “Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature.” Advances in Radiation Oncology, vol. 9, no. 1, July 2023, p. 101310. EBSCOhost, https://doi.org/10.1016/j.adro.2023.101310.
APA
Smart, A. C., Giobbie-Hurder, A., Desai, V., Xing, J. L., Lukens, J. N., Taunk, N. K., Sullivan, R. J., Mooradian, M. J., Hsu, C. C., Buchbinder, E. I., & Schoenfeld, J. D. (2023). Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature. Advances in Radiation Oncology, 9(1), 101310. https://doi.org/10.1016/j.adro.2023.101310
Chicago
Smart, Alicia C, Anita Giobbie-Hurder, Vineet Desai, Jessica L Xing, John N Lukens, Neil K Taunk, Ryan J Sullivan, et al. 2023. “Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature.” Advances in Radiation Oncology 9 (1): 101310. doi:10.1016/j.adro.2023.101310.